Sorry cant reply to PM. Based on my time in Europe, I see that they don't view their pharma products the way us Americans do. I think the reworking of the formula also will have to do with FDA regulations more so than potency.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.